Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Age Related Macular Degeneration Pipeline Landscape and Therapeutics Market 2016 Review


News provided by

RnR Market Research

08 Jul, 2016, 16:45 GMT

Share this article

Share toX

Share this article

Share toX

PUNE, India, July 8, 2016 /PRNewswire/ --

RnRMarketResearch.com adds "Age Related Macular Degeneration - Pipeline Review, H1 2016" offering information on comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration and special features on late-stage and discontinued projects.

Complete report on H1 2016 pipeline review of Age Related Macular Degeneration with 168 market data tables and 16 figures, spread across 579 pages is available at http://www.rnrmarketresearch.com/age-related-macular-degeneration-pipeline-review-h1-2016-market-report.html .

Companies discussed in this Age Related Macular Degeneration Pipeline Review, H1 2016 report include AC Immune SA, Achillion Pharmaceuticals, Inc., Aciont Inc., AdAlta Pty Ltd., Adverum Biotechnologies, Inc., Aerie Pharmaceuticals, Inc., Aerpio Therapeutics, Inc., Alimera Sciences, Inc., Alkeus Pharmaceuticals, Inc., Allergan Plc, Allinky Biopharma, Alteogen Inc., Amakem NV, Amarna Therapeutics B.V., Ampio Pharmaceuticals, Inc., Amyndas Pharmaceuticals LLC, Apellis Pharmaceuticals, Inc., Apexigen, Inc., Applied Genetic Technologies Corporation, Astellas Pharma Inc., Benitec Biopharma Limited, BIOCAD, Biokine Therapeutics Ltd., BioMAS Ltd., Biomics Biotechnologies Co., Ltd., Biophytis SAS, Boehringer Ingelheim GmbH, Caladrius Biosciences, Inc., Catalyst Biosciences, Inc., Cell Cure Neurosciences, Ltd., Charlesson LLC., Cipla Ltd., Clanotech AB, Clearside BioMedical, Inc., Clonz Biotech Private Limited, Coherus BioSciences, Inc., Colby Pharmaceutical Company, Crinetics Pharmaceuticals, Inc., Critical Pharmaceuticals Limited, Daiichi Sankyo Company, Limited, Delenex Therapeutics AG, Diffusion Pharmaceuticals Inc., Digna Biotech, S.L., Eleven Biotherapeutics Inc., Elsalys Biotech SAS, Exonate Limited, F. Hoffmann-La Roche Ltd., Foamix Pharmaceuticals Ltd., Formycon AG, Gene Techno Science Co., Ltd., Genentech, Inc., GenSight Biologics S.A., GlaxoSmithKline Plc, Grupo Ferrer Internacional, S.A., GTx, Inc., HanAll Biopharma Co., Ltd., Huabo Biopharm Co., Ltd., iCo Therapeutics Inc., Icon Bioscience, Inc., Iconic Therapeutics, Inc., Innovent Biologics, Inc., Intellect Neurosciences, Inc., International Stem Cell Corporation, Ionis Pharmaceuticals, Inc., Jeil Pharmaceutical Co., Ltd., Johnson & Johnson, Kadmon Corporation, LLC, Kala Pharmaceuticals, Inc., Kodiak Sciences, Inc., LeadArtis S.L., M's Science Corporation, Mabion SA, MacuCLEAR, Inc., Mitotech S.A., Mitsubishi Tanabe Pharma Corporation, Navigen Pharmaceuticals, Inc., Navya Biologicals Pvt Ltd, Neovacs SA, Neumedicines Inc., Neuroptis Biotech, Neurotech Pharmaceuticals, Inc., Novartis AG, Ocular Therapeutix, Inc., Ohr Pharmaceutical Inc., Omeros Corporation, Ophthotech Corp., Orphagen Pharmaceuticals, Inc., Oxford BioMedica Plc, PanOptica, Inc., Pfenex Inc., Pfizer Inc., Precision Ocular Ltd, Promedior, Inc., pSivida Corp., QLT Inc., Quark Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., RegenxBio Inc., Ribomic Inc., RXi Pharmaceuticals Corporation, SanBio, Inc., Santen Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., SciFluor Life Sciences, LLC, Sirnaomics, Inc., Stealth BioTherapeutics Inc., Sucampo Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., Sun Pharma Advanced Research Company Ltd., TRACON Pharmaceuticals, Inc., TWi Pharmaceuticals, Inc., Tyrogenex, Inc., VasGene Therapeutics, Inc., Wellstat Ophthalmics Corporation and Xbrane Biopharma AB.

Order a copy of Age Related Macular Degeneration - Pipeline Review, H1 2016 market research report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=627379 .

Another newly published market research report titled on Huntington Disease - Pipeline Review, H1 2016 provides comprehensive information on the therapeutic development for Huntington Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies Involved in Therapeutics Development and covered in this research include Addex Therapeutics Ltd, AFFiRiS AG, Angita B.V., Astellas Pharma Inc., Azevan Pharmaceuticals, Inc., BioCrea GmbH, BioMarin Pharmaceutical Inc., BrainStorm Cell Therapeutics Inc., Diffusion Pharmaceuticals Inc., EncephRx, Inc., Evotec AG , Galenea Corp., Genervon Biopharmaceuticals, LLC, Immungenetics AG, Ionis Pharmaceuticals, Inc., Ipsen S.A. , Kadmon Corporation, LLC, KineMed, Inc. , Living Cell Technologies Limited, Medesis Pharma S.A., Mitochon Pharmaceuticals, Inc., Neuralstem, Inc., Neurimmune Holding AG, NeuroNascent, Inc., New World Laboratories, Inc., nLife Therapeutics, S.L., NsGene A/S , Omeros Corporation, Oryzon Genomics S.A., Otsuka Holdings Co., Ltd., Pfizer Inc. , PharmatrophiX, Inc., ProQR Therapeutics N.V., QR Pharma, Inc., Raptor Pharmaceutical Corp., reMYND NV, Rhenovia Pharma Limited, Sangamo BioSciences, Inc., SOM Innovation Biotech SL, Spark Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., TyrNovo Ltd., Ultragenyx Pharmaceutical Inc., UniQure N.V., Vaccinex, Inc., Vertex Pharmaceuticals Incorporated, VistaGen Therapeutics , Inc., VivaCell Biotechnology Espana S.L., Voyager Therapeutics, Inc., Vybion, Inc., WAVE Life Sciences Ltd. and Wellstat Therapeutics Corporation. Huntington Disease Pipeline market research report of 303 pages is available at http://www.rnrmarketresearch.com/huntington-disease-pipeline-review-h1-2016-market-report.html .

Explore more reports on Ophthalmology therapeutics .

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.